How many insider declarations has F2 Vision SCS filed?

F2 Vision SCS has filed 3 public insider declarations with SEC (Form 4).

What is F2 Vision SCS's role?

F2 Vision SCS's reported role is not specified by the regulator across the filings.

Which companies does F2 Vision SCS report trades for?

F2 Vision SCS reports trades for Cullinan Oncology, Inc..

What is F2 Vision SCS's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 2.4M€.

← Executives ★ Sign in to follow

FV

F2 Vision SCS

Other

US·SEC (Form 4)

Cullinan Oncology, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€2m

▼ Sales (1 ops.)

Discover the full record of transactions filed by F2 Vision SCS. Director active across 1 company, notably Cullinan Oncology, Inc.. In total, 3 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €2.4m. Activity tracked since 12 May 2022. The latest transaction was disclosed on 12 May 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.

Declarations3 total

▼

F2 Vision SCS

Executives12 May 2022Cullinan Oncology, Inc.

$2M27SEC ↗

264,072 shares@ US$9.24970.24% mcap100.0% of flowCommon StockSEC:0001104659-22-061591:0

●

F2 Vision SCS

Executives11 Jan 2022Cullinan Oncology, Inc.

10SEC ↗

1,187,734 sharesCommon StockSEC:0000899243-22-001926:0

●

F2 Vision SCS

Executives11 Jan 2022Cullinan Oncology, Inc.

11SEC ↗

1,187,734 sharesCommon StockSEC:0000899243-22-001926

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

FV

F2 Vision SCS

Other

US·SEC (Form 4)

Cullinan Oncology, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€2m

▼ Sales (1 ops.)

Discover the full record of transactions filed by F2 Vision SCS. Director active across 1 company, notably Cullinan Oncology, Inc.. In total, 3 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €2.4m. Activity tracked since 12 May 2022. The latest transaction was disclosed on 12 May 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.

Declarations3 total

▼

F2 Vision SCS

Executives12 May 2022Cullinan Oncology, Inc.

$2M27SEC ↗

264,072 shares@ US$9.24970.24% mcap100.0% of flowCommon StockSEC:0001104659-22-061591:0

●

F2 Vision SCS

Executives11 Jan 2022Cullinan Oncology, Inc.

10SEC ↗

1,187,734 sharesCommon StockSEC:0000899243-22-001926:0

●